Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drugs & Aging

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11589340-000000000-00000PMID 21542658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Serotonergic Drugs and the Risk of Bleeding

  2011cited by this paper
• The Impact of Depression in Heart Disease

  2010cited by this paper
• Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis

  2010cited by this paper
• Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.

  2010cited by this paper
• High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors

  2010cited by this paper
• Risk of Ischemic Stroke Associated With Antidepressant Drug Use in Elderly Persons

  2010cited by this paper
• Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding.

  2010cited by this paper
• Safety of Selective Serotonin Reuptake Inhibitor Use Prior to Coronary Artery Bypass Grafting

  2010cited by this paper
• There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population‐based case–control study

  2010cited by this paper
• Use of Serotonergic Antidepressants and Bleeding Risk in Orthopedic Patients

  2010cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study

  2010cited by this paper
• The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes

  2010cited by this paper
• Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

  2010cited by this paper
• Serotonergic mechanisms enhance platelet-mediated thrombogenicity

  2009cited by this paper
• An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding.

  2009cited by this paper
• The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients

  2009cited by this paper
• The expanded biology of serotonin.

  2009cited by this paper
• Selective Serotonin Reuptake Inhibitors Are Associated With a Modest Increase in the Risk of Upper Gastrointestinal Bleeding

  2009cited by this paper
• Trends in Antidepressant Utilization From 2001 to 2004

  2009cited by this paper
• Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?

  2009cited by this paper
• Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.

  2009cited by this paper
• Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy

  2009cited by this paper
• Cardiovascular Abnormalities in Patients with Major Depressive Disorder

  2009cited by this paper
• Mirtazapine

  2009cited by this paper
• Antidepressant Drug Prescription and Risk of Abnormal Bleeding: A Case-Control Study

  2009cited by this paper
• Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women’s Ischemia Syndrome Evaluation (WISE) study

  2009cited by this paper
• Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

  2009cited by this paper
• Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting.

  2009cited by this paper
• Risk of clinically relevant bleeding in warfarin‐treated patients—influence of SSRI treatment

  2009cited by this paper
• Trends in antidepressant utilization from 2001 to 2004.

  2009cited by this paper
• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  2008cited by this paper
• Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip

  2008cited by this paper
• Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study

  2008cited by this paper
• The coadministration of paroxetine and low-dose aspirin synergistically enhances gastric ulcerogenic risk in rats.

  2008cited by this paper
• Serotonin transporter polymorphism and bleeding time during SSRI therapy.

  2008cited by this paper
• Trends in Antidepressant Prescriptions among the Elderly in Alberta during 1997 to 2004

  2008cited by this paper
• The Risk of Postpartum Hemorrhage With Selective Serotonin Reuptake Inhibitors and Other Antidepressants

  2008cited by this paper
• Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.

  2008cited by this paper
• Tolerability of Selective Serotonin Reuptake Inhibitors

  2008cited by this paper
• Pharmacogenetics and the serotonin transporter in late-life depression

  2008cited by this paper
• Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity

  2008cited by this paper
• Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins.

  2008cited by this paper
• Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.

  2008cited by this paper
• Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.

  2008cited by this paper
• Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism

  2008cited by this paper
• Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants

  2008cited by this paper
• Depressive Symptoms and Risk of Stroke: The Framingham Study

  2007cited by this paper
• Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.

  2007cited by this paper
• Bleeding gums: duloxetine may be the cause.

  2007cited by this paper
• Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

  2007cited by this paper
• Clinical practice. Late-life depression.

  2007cited by this paper
• Coated‐platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors

  2007cited by this paper
• Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.

  2007cited by this paper
• Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes.

  2007cited by this paper
• Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population

  2007cited by this paper
• Depression and coronary heart disease: more pieces of the puzzle.

  2007cited by this paper
• Influence of antidepressants on hemostasis

  2007cited by this paper
• Common genetic factors for depression and cardiovascular disease

  2007cited by this paper
• Depression and cardiovascular comorbidity

  2007cited by this paper
• Selective Serotonin Reuptake Inhibitors and Risk of Hemorrhagic Stroke

  2007cited by this paper
• Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.

  2007cited by this paper
• Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

  2007cited by this paper
• Does treating depression improve survival after acute coronary syndrome?

  2007cited by this paper
• Effects of antidepressant treatment following myocardial infarction

  2007cited by this paper
• Late-Life Depression

  2007cited by this paper
• Adverse Cardiovascular Events in Antidepressant Trials Involving High-Risk Patients: A Systematic Review of Randomized Trials

  2006cited by this paper
• Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

  2006cited by this paper
• Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.

  2006cited by this paper
• Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors

  2006cited by this paper
• Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.

  2006cited by this paper
• Antidepressants and risk of upper gastrointestinal bleeding.

  2006cited by this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Requirement for Allogeneic Red Blood Cell Transfusion Following Coronary Artery Bypass Surgery

  2006cited by this paper
• Depression and cardiovascular disease: healing the broken-hearted.

  2006cited by this paper
• Past use of selective serotonin reuptake inhibitors and the risk of cerebrovascular events in the elderly

  2005cited by this paper
• Coated-platelets: an emerging component of the procoagulant response.

  2005cited by this paper
• Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

  2005cited by this paper
• Does concurrent prescription of selective serotonin reuptake inhibitors and non‐steroidal anti‐inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

  2005cited by this paper
• General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction

  2005cited by this paper
• Hypothesis: Antiplatelet Effects of Selective Serotonin Reuptake Inhibitors Cause Clinical Benefits on Cardiovascular Disease and Increase Risks of Bleeding

  2005cited by this paper
• Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease.

  2005cited by this paper
• Depression, alterations in platelet function, and ischemic heart disease.

  2005cited by this paper
• Antidepressants, Warfarin, and the Risk of Hemorrhage

  2005cited by this paper
• Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis

  2004cited by this paper
• Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.

  2004cited by this paper
• Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.

  2004cited by this paper
• Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000

  2004cited by this paper
• Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis

  2004cited by this paper
• Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction

  2004cited by this paper
• Depression Treatment in a Sample of 1,801 Depressed Older Adults in Primary Care

  2003cited by this paper
• Poststroke depression: prevalence, diagnosis, treatment, and disease progression.

  2003cited by this paper
• Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.

  2003cited by this paper
• Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

  2003cited by this paper
• Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

  2003cited by this paper
• Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

  2003cited by this paper
• Epidemiology of comorbid coronary artery disease and depression.

  2003cited by this paper
• Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction

  2003cited by this paper
• Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.

  2003cited by this paper
• Epidemiology of late-life mental disorders.

  2003cited by this paper
• A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients.

  2003cited by this paper
• Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study

  2002cited by this paper

• Association between concomitant use of direct oral anticoagulants with antidepressants and an increased risk of hemorrhage: analysis of the food and drug administration adverse event reporting system database

  2026cites this paper
• Bleeding Risk Following Total Shoulder Arthroplasty in Patients Using Selective Serotonin Reuptake Inhibitors.

  2026cites this paper
• Impact of Antidepressant Use and Serotonergic Profile on Short-Term Outcome of Traumatic Brain Injury: Retrospective Nationwide Cohort Study.

  2026cites this paper
• Systematic Review on Antidepressant Use and Bleeding Risk After Dental Extractions: Evidence Gaps and Clinical Implications

  2025cites this paper
• Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care

  2025cites this paper
• 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee.

  2025cites this paper
• A Nationwide Cohort Study on Antidepressant Use and Stroke Risk in Young Adults Aged 18-44 Years.

  2025cites this paper
• Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function

  2025cites this paper
• Clinical Implications of Antidepressants and Associated Risk of Bleeding: A Narrative Review

  2025cites this paper
• Association of SSRI and SNRI use with incidence of cardiovascular events in veterans with giant cell arteritis and polymyalgia rheumatica

  2025cites this paper
• Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation

  2025cites this paper
• Acute selective serotonin-reuptake inhibition elevates basal ventilation, attenuates the rebreathing ventilatory response, independent of cerebral perfusion.

  2025cites this paper
• Does Concomitant Use of Antidepressants and Direct Oral Anticoagulants Increase the Risk of Bleeding?

  2025cites this paper
• Serotonin-mediated regulation of mitophagy in Alzheimer's disease: mechanistic insights and therapeutic potential.

  2025cites this paper
• Antidépresseurs et risque hémorragique

  2025cites this paper
• Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding

  2024cites this paper
• Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review

  2024cites this paper
• Comparative Targeted Metabolomics of Ischemic Stroke: Thrombi and Serum Profiling for the Identification of Stroke-Related Metabolites

  2024cites this paper
• Psychopharmacological treatment in patients planned for hip or knee replacement

  2024cites this paper
• Platelet Function in Mood Disorders: Interplay, Clinical Implications, and Future Perspectives – A Narrative Review

  2024cites this paper
• Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial

  2024cites this paper
• Tyrosine phosphorylation of YAP‐1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin

  2023cites this paper
• The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies.

  2023cites this paper
• Adverse effects of trazodone in dogs on primary hemostasis and electrocardiogram: A single‐blinded placebo‐controlled crossover study

  2023cites this paper
• Perspective Chapter: New Use of the SSRI Fluvoxamine in the Treatment of COVID-19 Symptoms

  2023cites this paper
• Hematochezia caused by tandospirone in a patient with major depressive disorder and anxious distress: a case report

  2023cites this paper
• Using machine learning to develop a clinical prediction model for SSRI-associated bleeding: a feasibility study

  2023cites this paper
• Use of Antidepressants and the Risk of Upper Gastrointestinal Tract Bleeding: A Case-Control Study.

  2023cites this paper
• Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain

  2023cites this paper
• Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors.

  2023cites this paper
• Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study

  2022cites this paper
• Recognizing Depression in the Elderly: Practical Guidance and Challenges for Clinical Management

  2022cites this paper
• Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants

  2022cites this paper
• Use of tramadol and the risk of bleeding complications in patients on oral anticoagulants: a systematic review and meta-analysis

  2022cites this paper
• Evaluation of Bleeding in Orthopedic Surgery With Perioperative Use of Serotonergic Antidepressants

  2022cites this paper
• Determination of Mefenamic Acid in Aqueous Solutions Using Reverse - Continuous Flow Injection Analysis

  2022cites this paper
• Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

  2022cites this paper
• Is depression the contraindication of anterior cervical decompression and fusion for cervical spondylosis?

  2022cites this paper
• Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study

  2022cites this paper
• Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis

  2022cites this paper
• Incidence of bleeding events in patients on concomitant tyrosine kinase inhibitors and selective serotonin reuptake inhibitors

  2022cites this paper
• Psychotropic Medications and Heart

  2022cites this paper
• Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study

  2022cites this paper
• Integrated Care of Alcohol-Related Liver Disease.

  2022cites this paper
• Antiplatelet Effect of Mirtazapine via Co-blocking of the 5-HT2A and α2-Adrenergic Receptors on Platelets.

  2021cites this paper
• Serotonin‐Affecting Antidepressant Use in Relation to Platelet Reactivity

  2021cites this paper
• Comparison of risk of cardiovascular disease related adverse events between selective serotonin reuptake inhibitor users and serotonin norepinephrine reuptake inhibitor users in Korean adult patients with depression: retrospective cohort study.

  2021cites this paper
• European Journal of Pharmacology - Regular article the antiplatelet effect of mirtazapine is mediated by co-blocking 5-HT2A and α2-adrenergic receptors on platelets: An in vitro human plasma-based study.

  2021cites this paper
• Exploring the antiplatelet activity of serotonin 5-HT2A receptor antagonists bearing 6-fluorobenzo[d]isoxazol-3-yl)propyl) motif- as potential therapeutic agents in the prevention of cardiovascular diseases.

  2021cites this paper
• Chronic Subdural Hematoma with Psychiatric Disorders

  2021cites this paper
• Outcomes of Direct Oral Anticoagulants Co-Prescribed with Common Interacting Medications.

  2021cites this paper
• Serotonergic Antidepressants and Risk for Traumatic Intracranial Bleeding

  2021cites this paper
• Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular risk

  2021cites this paper
• SSRIs: Applications in inflammatory lung disease and implications for COVID‐19

  2021cites this paper
• A Case of Unexpected Ecchymosis Associated With a High Dose of Venlafaxine.

  2021cites this paper
• Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal Detection

  2021cites this paper
• JİNEKOLOJİ HASTALARINDA SELEKTİF SERATONİN GERİ ALIM İNHİBİTÖRLERİ KULLANMANIN KANAMA ÜZERİNE ETKİSİNİN DEĞERLENDİRİLMESİ

  2021cites this paper
• Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis

  2021cites this paper
• Pain management in hemophilia: expert recommendations

  2021cites this paper
• Medication Related Problems.

  2021cites this paper
• Platelets promote epileptic seizures by modulating brain serotonin level, enhancing neuronal electric activity, and contributing to neuroinflammation and oxidative stress.

  2020cites this paper
• Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes

  2020cites this paper
• An updated classification of antidepressants: A proposal to simplify treatment

  2020cites this paper
• Post-Stroke Depression: Chaos to exposition.

  2020cites this paper
• Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery

  2020influential citation
• SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients.

  2020cites this paper
• Neuromodulation and Plasticity in the Respiratory Tract

  2020cites this paper
• Antidepressant drug use and subdural hematoma risk

  2020cites this paper
• Antidepressant treatment in patients following acute coronary syndromes: a systematic review and Bayesian meta‐analysis

  2020cites this paper
• Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding

  2020cites this paper
• Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain

  2020cites this paper
• Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case–control study

  2020cites this paper
• Adverse Drug Events in Patients with Chronic Kidney Disease Associated with Multiple Drug Interactions and Polypharmacy

  2020cites this paper
• Choosing among second-generation antidepressant treatments for depressed patients with cardiac diseases

  2019cites this paper
• Management of Late-Life Depression.

  2019cites this paper
• Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis

  2019cites this paper
• Preadmission use of antidepressants and risk of complications and death after colorectal cancer surgery: a nationwide population‐based cohort study

  2019cites this paper
• Arzneimittelinteraktionen, die man kennen muss!

  2019influential citation
• Psychological Considerations in Hematopoietic Stem Cell Transplantation.

  2019cites this paper
• Arzneimittelinteraktionen, die man kennen muss!

  2019cites this paper
• Arzneimittelinteraktionen, die man kennen muss!

  2019cites this paper
• Drug-associated valvular heart diseases and serotonin-related pathways: a meta-analysis

  2019cites this paper
• Essential Medical Work-Up and Rule Outs

  2019cites this paper
• Depression, antidepressants and the risk of cardiovascular events and death in older men.

  2019cites this paper
• Spinal Epidural Hematoma after Interlaminar Cervical Epidural Steroid Injection.

  2019cites this paper
• Degree of serotonin reuptake inhibition of antidepressants and ischemic risk

  2019cites this paper
• Bleeding and Elevated INR Secondary to Concomitant Tramadol and Warfarin Administration.

  2019cites this paper
• Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation

  2019cites this paper
• Reversible platelet aggregation in the presence of calcium ions: mechanisms and potential value

  2019cites this paper
• Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis

  2019cites this paper
• Serotonin reuptake inhibitors and bleeding risks related to elderly submitted to major orthopedic surgery

  2019cites this paper
• The impact of selective serotonin receptor inhibitors on post-endoscopic sphincterotomy bleeding, alone or with concurrent aspirin or nonsteroidal anti-inflammatory drugs

  2019cites this paper
• Clinically relevant drug interactions between newer antidepressants and oral anticoagulants

  2019cites this paper
• Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial

  2019cites this paper
• RISKS OF HOSPITALIZATION FOR UPPER GASTROINTESTINAL BLEEDING IN SELECTIVE SEROTONIN REUPTAKE INHIBITORS USERS AFTER HELICOBACTER PYLORI ERADICATION THERAPY: A PROPENSITY SCORE MATCHING ANALYSIS Running title: UGIB risk of SSRI

  2019cites this paper
• Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS): A Randomized Controlled Study

  2018cites this paper
• Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach

  2018cites this paper
• Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

  2018cites this paper
• Re: Changes in anti‐müllerian hormone levels as a biomarker for ovarian reserve after ultrasound‐guided high‐intensity focused ultrasound treatment of adenomyosis and uterine fibroid

  2018cites this paper
• Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport

  2018cites this paper